BUSINESS ALIGNMENT PUBLIC COMPANY LIMITEDSET: BIZ🇹🇭 TH

Business Operation · 2025

Corporate Information

Company Name

BUSINESS ALIGNMENT PUBLIC COMPANY LIMITED

Telephone

0-2636-6828-9

Website

www.bizalignment.com

Email

ir@bizalignment.com

Dividend Policy

Dividend Policy

The Company's dividend payout policy is to pay at least 40 percent of net profit after deduction all categories of reserves as specified in applicable laws and the Company's Article of Association. However, dividend payment is subject to operating results, financial status, investment plans, suitability, and not significantly impact the Company's operation. Dividend payment must seek approval from the Annual General Meeting of Shareholders. An exception applies to interim dividend payment, which the Board of Directors has the authority to approve and report to the following shareholders' meeting.

Historical Dividend Payments

This YearLast Year2 Years Ago3 Years Ago4 Years AgoMetricDescriptionRemark
0.50.370.330.220.7Net profit per share (Baht : Share)Net profit per share (baht : share)
0.50.350.30.20.68Dividend per share (Baht : Share)Dividend per share (baht : share)
Regarding the dividend per share for 2025, the Board of Directors' Meeting No.2/2026 resolved to propose in the 2026 Annual General Meeting to approve the dividend payment from the net profit of the year 2025 to shareholders in the amount of 0.50 baht per share for 600,734,989 shares, totaling 300,367,494.50 baht.
00002Dividend stock ratio (Number of original shares: dividend shares)Ratio of stock dividend payment (existing share : stock dividend)
00000.25Dividend share value per share (Baht : Share)Value of stock dividend per share (baht : share)
0.50.350.30.20.93Total dividend payment value (Baht : Share)Total dividend payment (baht : share)
99.9795.0792.1692.3188.01Dividend payout ratio to net profit (%)Dividend payout ratio compared to net profit (%)

Major Shareholders

Major Shareholders

No.NameShares% SharesParent No.
14,937Mr. Sompong Chunekitiyanone192,705,00032.08
14,938Group of Mr. Voravid Silapusid185,982,00030.96
14,939Mr. Voravid Silapusid181,500,00030.2114,938
14,940Mrs. Sivika Silapusid4,482,0000.7514,938
14,941UBS AG LONDON BRANCH64,402,90010.72
14,942Mr. Noppadol Suntanaphanich36,000,0005.99
14,943Mr. Kittipong Phatarachaikul14,124,7002.35
14,944Mrs. Sarin Chinudomsap7,500,0001.25
14,945Mr. Kittisak Chinudomsap7,009,6501.17
14,946Thai NVDR Company Limited6,912,0991.15
14,947Mr. Chanon Chinudomsap3,000,0000.5
14,948Mr. Prajak Tovatanasatid1,963,8500.33

Business Strategies Overview

Vision

To be a leader in distributing and providing medical and healthcare services, particularly in the treatment and prevention of cancer, in order to make modern technology accessible and comparable to that of developed countries.

Objectives

To provide medical equipment as well as medical and healthcare services, particularly in cancer treatment and prevention, ensuring that the public has access to modern technology on par with developed countries.

Goals

To become a central hub for advancing cancer treatment in collaboration with hospitals, doctors, and other medical professionals, particularly through radiotherapy, to enhance the quality of life for cancer patients and ensure access to treatment technologies on par with developed countries.

Business Strategies

The Company operates with a strong focus on governance, integrity, and transparency, while continuously developing the efficiency and capabilities of its personnel. It also maintains close and ongoing collaboration with manufacturers to ensure that its deliverables meet quality and standards that exceed customer expectations, achieving the highest level of satisfaction. The Company focuses on its strength as a "Solution Provider" in cancer treatment through radiotherapy, offering not only high-quality, state-of-the-art radiotherapy medical equipment but also comprehensive consulting services to hospitals. These services include designing radiotherapy buildings or treatment rooms, supervising construction projects, installing equipment, training hospital staff, and providing maintenance services to ensure hospitals can deliver high-quality care to cancer patients.

Other Information

NameDescription
Mission
  1. To import, distribute, and provide medical services, including medical products, in order to enable doctors and related medical professions to treat patients with modern technology, and to facilitate patients in accessing such technology.

  2. To be a hub to develop a treatment in collaboration with hospitals, doctors, and medical professions, particularly in cancer, to provide a quality of life comparable to that of developed countries.

  3. To administer and manage under the corporate governance and medical ethics, in order to ensure effective and efficient management and operations.

  4. To create the highest level of satisfaction for all stakeholders, both directly and indirectly, in terms of quality, price, delivery, and international-level services.

  5. To look for and expand businesses related to healthcare and public health to prevent and encourage to have the quality of life, as well as to increase revenue and profitability.

Core Value

B Beyond the best Every time you act, make sure you can do "MORE" with the word "BEST" every time.

A Accountability Responsibility is the basis of success.

O Openness Openness increases credibility and is the key to success.

N Never give up The secret of success is that we never give up.

E Expertise Expertise is about knowing and understanding more than "just knowing".

Long-term Goal

Apart from being a distributor and installer of high-quality medical equipment and software systems, including tools related to cancer treatment through radiotherapy, the Company continues to look for and expand businesses related to healthcare and public health to be a leader in the treatment and prevention of cancer. It aims to make modern technology accessible and comparable to that of developed countries, including encouraging people to have the quality of life.

The establishment of a specialized hospital focused on cancer, providing consultation and patient referral services, in order to offer treatment services in both radiotherapy and chemotherapy. The hospital aims to prioritize the quality of the treatment to meet the standards and the expertise of specialized doctors, as well as efficiency and safety in accordance with global standards. It is another business that the Company has undertaken to enhance a long-term business which expand the scope of business beyond the distribution and installation of medical equipment for radiotherapy. Additionally, it also provides more opportunities and options to patients as well as mitigating risks. Expansion will provide opportunities in terms of income and generate a more stable cash flow. By operating the hospital officially on October 1, 2019, the Company aims to achieve the hospital’s operating results within 3-5 years. In line with the Company’s vision, the aim is to make modern technology accessible and comparable to that of developed countries. It is estimated that another branch of the hospital will be opened in another region within five years. However, the Company will closely study the feasibility of this project.

With the advancement of Next Generation Sequencing (NGS) technology, which is highly accurate and secure, it is now possible to access, examine, and uncover the secrets linked to each individual’s unique genetic code. This enables the evaluation of personal lifestyle factors such as diet, exercise, and skincare. It provides more effective healthcare planning.

In this regard, the aforementioned is an expansion of the Company’s business. It is part of the long-term business strategy to enhance the potential for sales stability.

Awards

Year

Awards

2022

SET Awards 2022 by the Stock Exchange of Thailand

  • Outstanding Company Performance Awards, Business Excellence, mai market capitalization of over 1.5 billion baht

  • Outstanding CEO Awards, Business Excellence, "Mr. Sompong Chuenkitityanone"

2020

  • Certified for quality management system standards for the distributors of medical instruments and devices EN ISO13485: 2016 from TUV SUD Product Service GmbH, Germany

  • Chosen to be in the “ESG Emerging List”

2019

  • "Special Recognition under Rising Star Awards 2018", National Director Conference 2019 by Thai Institute of Directors

2018

  • The Outstanding Executive of the Year 2018 in Business Administration and Management,
    "Mr. Sompong Chunekitiyanone" by one million merit projects.

2017

  • "SMEs Excellence Awards 2017" : Silver Award, Trading category by TMA.

Material Changes & Developments

Material Changes & Developments

YearDescription
2,000
  • Registered with a registered capital of one million baht.

  • Appointed to be a distributor of Varian Medical Systems Inc. (Currently known as Varian, a Siemens Healthineers Company “Varian”)

2,006

Transformed the business policy to become a Solution Provider for cancer treatment. The Company would source and provide related equipment and fixtures, as well as undertake construction and facility upgrades to be suitable for cancer treatment in both public and private hospitals for supporting the rapid expansion and meeting the changing purchasing behaviors of the customers.

2,010

Signed a contract with Chulabhorn Hospital for the sale and installation of TrueBeam linear accelerator including the renovation of the radiation room. The aforementioned machine was a modern, highly accurate machine and the first of its kind in Southeast Asia at that time.

2,012

Signed the contracts for the purchase and installation of TrueBeam linear accelerator, as well as the facility upgrading, with Songklanagarind Hospital in Songkla province (one unit), Srinagarind Hospital in Khon Kaen province (one unit), King Chulalongkorn Memorial Hospital, the Thai Red Cross Society (two units), and the Faculty of Medicine Siriraj Hospital, Mahidol University (one unit). As a result, Thailand had the highest number of TrueBeam linear accelerator in use in Southeast Asia at that time.

2,016
  • Transformed into public company limited

  • Listed on the Market for Alternative Investment (mai) and commenced its trading under the name "BIZ"

2,017

Signed the contract with King Chulalongkorn Memorial Hospital, the Thai Red Cross Society for the Proton Center project.

2,018
  • Cancer Alliance Company Limited was established

  • Grand Opening of "BIZGenes" Genetic Testing for personalized healthcare

2,019

Cancer Alliance Company Limited started its operation of "Sriracha Cancer Alliance Hospital" (CAH) which is a specialized hospital focused on cancer treatment located at Chonburi province.

2,022

BIZ had been moved from the Market for Alternative Investment (mai) to the Stock Exchange of Thailand (SET)

2,025

"Business Alignment (Cambodia) Company Limited" (an associated company) was established in Cambodia.

Use of Proceeds from Securities Offerings

Is There Money Raised from a Securities Offering Still to Report On?

No

Commitments Made in the Registration Statement

Are There Commitments or Conditions from an Offering or Listing?

No

Group Operating-Structure Policy

Description

The Company has one subsidiary and one associate company, with shareholding proportions of 73.97% and 40.00%, respectively.

Companies Where the Company Holds ≥10%

Companies (≥10% Holding)

Company NameAddressProvinceZip CodeTelephoneBusiness TypeSecurity TypeSharesPaid-up Shares
Cancer Alliance Company LimitedNo. 529, Moo 3, Nongkham, SrirachaChonburi20230033 046 333Hospital Business (Specialised in Cancer Treatment)Common shares2,588,9993,500,000
Cancer Alliance Company LimitedNo. 529, Moo 3, Nongkham, SrirachaChonburi20230033 046 333Hospital Business (Specialised in Cancer Treatment)Common shares2,588,9993,500,000
Business Alignment (Cambodia) Company LimitedGIA Tower, G1007, 10F, Tonle Basak, Chamkar Mon, Phnom Penh, CambodiaForeign country+855 92 343 701Import, distribution, installation and maintenance of medical equipmentCommon shares4001,000

Shareholders with Potential Conflict of Interest

Has Potential-Conflict Shareholder (Y/N)

No

Relationships Among Major Shareholders

Relationship Exists (Y/N)

No

Shareholders' Agreement

Agreement Exists (Y/N)

No

Shareholding Diagram (Group Structure)

Does the company hold shares in other companies?

Yes

Subsidiaries

Company NameJuristic Persons / Holders
Cancer Alliance Company LimitedBUSINESS ALIGNMENT PUBLIC COMPANY LIMITED · Voting rights percent: 73.97 · Shareholding proportion percent: 73.97

Associated Companies

Company NameJuristic Persons / Holders
Business Alignment (Cambodia) Company LimitedBUSINESS ALIGNMENT PUBLIC COMPANY LIMITED · Voting rights percent: 40.0 · Shareholding proportion percent: 40.0

Income Structure

Introduction

The Company's revenue is categorized as follows:

  1. Sales revenue: selling and installation of the medical equipment

  2. Service revenue: it consists of 1) radiological equipment service, which offers repair, maintenance, and software system upgrades for radiation machine and related equipment, and 2) gene screening service.

  3. Construction revenue: the building construction for the installation of the radiation machine which began in Q4/2024 and and completed in Q3/2025.

  4. Hospital operations revenue: the Company's subsidiary (Cancer Alliance Company Limited) operates a specialized hospital for cancer treatment. The hospital's services include cancer diagnosis and screening, radiation therapy, chemotherapy, elderly care, as well as nutritional and dietary services for cancer patients.

Product / Service Income

CategoryDescriptionThis YearThis Year %Last YearLast Year %2 Years Ago2 Years Ago %
Total revenue from operationsTotal revenue from operations2,024,1311001,714,1801001,688,974100
Revenue from Sales1,323,32465.381,049,212.7861.211,148,65468.01
Revenue from Construction23,1151.1413,395.030.7800
Revenue from Hospital Operations106,9565.28106,1646.19103,0256.1
Other Revenue000000
Revenue from Service-Radiation Machine Operating Segments568,19628.07544,09931.74435,35725.78
Revenue from Service-Genetic Testing Service Operating Segments2,5400.131,3090.081,9370.11
OtherOthers000000

Export Income

CategoryDescriptionThis YearThis Year %Last YearLast Year %2 Years Ago2 Years Ago %
Total revenueTotal revenue2,024,1311001,714,1801001,688,974100
DomesticDomestic2,015,51299.571,563,96091.241,681,624.5199.56
InternationalInternational8,6190.43150,2208.767,349.490.44
CambodiaCambodia8,619100150,2201007,349.49100
Other countriesOthers000000

Other Income

Operating Other IncomeNon-Operating Other IncomeShare of Profit
1710 · As of year: 2367.0 · Description: Total other income · As of yesteryear: 2980.0 · As of year before yesteryear: 6709.0 · 1711 · As of year: 0.0 · Description: Other income from operations · As of yesteryear: 0.0 · As of year before yesteryear: 0.01712 · As of year: 2367.0 · Description: Other income not from operations · As of yesteryear: 2980.0 · As of year before yesteryear: 6709.01713 · As of year: -154.0 · Description: Share of profit · As of yesteryear: 0.0 · As of year before yesteryear: 0.0

Product / Service Characteristics

Introduction

The Company's main product is treatment delivery, particularly Linear Accelerator, which is the essential equipment used in cancer treatment through teletherapy. This equipment is significant and valuable. Additionally, the Company acts as a Solution Provider, taking responsibility for sourcing comprehensive equipment and services to ensure efficient utilization of treatment delivery. Therefore, the Company's role includes sourcing since the construction, upgrading radiation rooms to meet standards, and sourcing other necessary equipment to complement treatment delivery for enhancing the treatment process. The aforementioned equipment includes a CT simulator, a treatment planning system, an oncology information system, a quality assurance and pretreatment verification tool, as well as other accessory equipment. The Company also provides maintenance service to maintain the performance and longevity of the treatment delivery and related equipment.

Business Type

3115

Business Groups

Business GroupDescription
Treatment Delivery Equipment

This is the Company's main product, which is the equipment used in radiotherapy and holds the highest value compared to the Company's other functions or products.

Linear Accelerator

The equipment for teletherapy involves cancer treatment using radiation from high-energy X-rays directed from a distance onto the cancer cells' area to destroy them. This state-of-the-art technology boasts high accuracy and can be applied to various cancer cells throughout the body. It serves as the main revenue source for the Company.

The linear accelerator, which the Company imports and distributes, come from Varian, A Siemens Healthineers Company ("Varian"). Varian is a globally leading company in cancer treatment technology, specializing in radiation therapy, including Brachytherapy Afterloader. Varian's cutting-edge and advanced technologies are well-known in the medical radiation therapy field, both domestically and internationally.

Brachytherapy Afterloader

The products used in the treatment of cancer through brachytherapy involve the use of small radioactive sources tightly encapsulated, which are inserted closely or into the area or tumor intended for treatment. This typically uses Iridium-192, which emits radiation. It is inserted into the cancerous organ through specialized tools. This type of treatment can deliver a high dose of radiation precisely to the cancerous organ and at the specific point, reducing damage to the surrounding tissues around the tumor. Therefore, it is suitable for treating certain types of cancer, such as gynecological cancers.

Proton Therapy

Product used for cancer treatment with remote proton radiation therapy are developed by IBA, Belgium. Protons are accelerated by a particle accelerator to nearly the speed of light. Proton radiation exhibits a unique characteristic called the Bragg peak, which allows for lower penetration through healthy tissue compared to X-rays. The penetration depth of proton radiation can be precisely controlled, ensuring it does not extend beyond the cancerous tissue. This enables effective energy transfer to destroy tumors or cancer cells while minimizing damage to surrounding healthy tissues or organs near the tumor site. Proton radiation delivers significantly less energy to nearby healthy tissues, reducing damage or destruction. Additionally, proton therapy machines allow precise adjustment of beam size and intensity, enabling highly accurate targeting of tumors. As a result, proton radiation therapy can precisely destroy tumors or cancer cells with maximum accuracy, while nearby healthy organs receive minimal or no radiation exposure. This ensures highly effective cancer treatment and significantly reduces side effects.

Equipment and System

The products which related to advanced technology equipment and systems, designed to complement radiation therapy processes in treating patients. Key products in this category include CT Simulators, hardware, and software for Treatment Planning System and Oncology Information System, all used in conjunction with radiation therapy machines.

CT Simulator

Products that resemble and function similarly to conventional computed tomography (CT) machines but have some distinctive features. For example, they feature a flat, table-like bed similar to those in radiation therapy rooms, with larger openings to accommodate patients wearing immobilization devices. These machines include software that enables visualization of the actual position, size, and shape of cancerous tumors and surrounding normal organs. The software assists in aligning the radiation beams and determining the position of radiation-blocking devices on the computer screen. Once images and treatment plans are obtained, they are forwarded to the treatment planning computer for accurate calculation of the radiation dose according to the doctor's specifications, ensuring patient safety. Presently, these CT simulators come in both three-dimensional and four-dimensional configurations.

Treatment Planning System

The treatment planning software system designed to deliver precise radiation therapy to cancerous tumors. It enables accurate targeting of the tumor while minimizing radiation exposure to surrounding healthy tissues. The modern computer-based treatment planning system can plan treatments using various techniques, such as 2D and 3D planning, Intensity Modulated Radiation Therapy (IMRT), and Volumetric Modulated Arc Therapy (VMAT). The system utilizes CT images of the patient obtained from a CT simulator in 3D or 4D to create treatment plans. Radiologists can specify the size and shape of the target to be treated, and medical physicists will plan treatments using different techniques and computational processing to evaluate the radiation distribution within the target tumor and surrounding tissues. After the radiologist approves the treatment plan, medical physicists send the plan through a high-speed computer network to the radiation therapy machine for the actual treatment.

Oncology Information System

This software is designed to record and review the total amount of radiation a patient receives throughout high-efficiency radiation therapy treatments. It also serves as an information system for radiation therapy that supports the hospital's electronic health record system. It includes appointment scheduling for patients in radiation oncology and oncology clinics. It is suitable for patients undergoing both radiation therapy and chemotherapy. Additionally, it can support an image data management system in radiation therapy to verify the accuracy of the treatment area and the positioning of radiation to ensure that it aligns with the treatment plan.

Other Equipment

This product group consists of components of the main products, such as applicators for the afterloader or products that are equipment used in the treatment process. It includes devices for quality assurance and pretreatment verification tool, Gafchromic films, equipment for monitoring patient movement during imaging, and devices for immobilizing patients during treatment.

Services

It is divided into two types as follows:

  1. Maintenance services for medical equipment, which has exceeded its 1-2 year warranty period stipulated in the sales contract, depend on each individual contract.

  2. Genetic testing services to assess lifestyles, such as dietary habits, exercise routines, and skincare, as well as identifying the risk of common cancers. The test results are personalized, involving the detection of gene mutations, and are sent to the genetic laboratory for analysis, providing a source of income for the Company.

Hospital Operations

The subsidiary (Cancer Alliance Company Limited), which is the specialized hospital for cancer treatment. The Company recognized the revenue based on the shareholding proportion (73.97 percent).

Research & Development

Has R&D Policy (Y/N)

No

R&D Cost — Label

Research and development (R&D) expenses over the past 3 years (Million Baht)

R&D Cost — This Year

0.0

R&D Cost — Last Year

0.0

R&D Cost — 2 Years Ago

0.0

Assets Used in the Business

Permanent Assets — Description

Details are as shown in "Attachment 4."

Intangible Assets — Description

Details are as shown in "Attachment 4."

Has Subsidiaries Investment Policy (Y/N)

Yes

Subsidiaries Investment Policy — Description

In considering investments in subsidiaries or associates, as well as individual investment projects, the Company prioritizes on evaluating businesses that support and benefit the Company's operations. This includes assessing the return on investment, risks, and the financial condition of the Company thoroughly. Such investments must be considered by the Board of Directors and shareholders in accordance with the defined scope of authority. This is committed to compliance with regulations and announcements of the Securities and Exchange Commission and the Stock Exchange of Thailand, as well as relevant laws, regulations, or orders. The Company exercises control through the appointed representatives to serve as directors in subsidiary for ensuring the alignment with the Company's direction and management policies.

Marketing Policy & Competition

Reporting Mode

3117

Marketing Policy (Overall)

The treatment delivery equipment and related accessories that the Company imports and distributes are considered unique and employ advanced technology. This has a significant impact on the overall industry, where there are few manufacturers, and specialists are crucial for these specific products.

Industry & Competition (Overall)

LINAC Manufacturers

The manufacture of radiation therapy machines requires advanced technology, resulting in a limited number of manufacturers. Currently, Thailand is unable to produce these machines domestically, and thus relies on imports from foreign countries. Examples of imported products include those from Varian, A Siemens Healthnieers Company and Elekta AB which based in Sweden. Both companies are major manufacturers and primary distributors in the global radiation therapy machine market. Additionally, there are radiation therapy machines from China, which have a relatively small market share globally and are often specialized for specific purposes.

The Provider of Genetic Testing for Personalized Health Plan and Cancer Risk Screening

The genetic testing service is not a new offering in Thailand but has been available for a long time. However, information may not be accessible to the general public regarding the current availability of services that can delve into the DNA’s genetic level. These services aim to provide a deeper understanding of persons’ health conditions related to their lifestyles, including the risk of hereditary cancer or environmental factors that may contribute to cancer. The general public might not fully grasp the importance or necessity of obtaining such information for planning their health care and future. Furthermore, there is limited awareness of the current advanced technologies for analyzing this genetic information. Therefore, the current competition is focused on providing comprehensive and accessible information to the public, both directly and indirectly, about the availability of these services.

Competition in Thailand

The medical equipment import industry is a continuously growing sector, particularly in the field of advanced medical technologies such as radiotherapy machines. Currently, there are only two major companies involved in importing and distributing radiotherapy products, tools, and related equipment in Thailand. The Company serves as the distributors for Varian's radiotherapy products. The other company is Elekta AB, which is a significant competitor to Varian in the global market. This competitive landscape defines the industry, where distributors and major manufacturers, such as Varian and Elekta AB, play a crucial role. Despite the presence of specialized and unique radiotherapy machines like CyberKnife and TomoTherapy from Accuray, a U.S.-based company, as well as products from Chinese manufacturers like Shinva Medical Instrument, these entities are not considered primary competitors.


The number of radiation machines in Thailand can be categorized based on the domestic market share as follows:

No.

Radiation Machine

Number of Machines

Market Shares (%)

1

LINAC Varian

77

55.00

2

LINAC Elekta

47

33.57

3

Other Accelerators and/or Old Technology

16

11.43

Procurement of Products & Services

Reporting Mode

3117

Procurement (Overall)

The Company operates as a Solution Provider in the field of radiation therapy for hospital clients. Consequently, most product sales take the form of project-based work. The Company is responsible for tasks ranging from construction, upgrading radiation rooms, procuring and installing medical equipment, and related devices for radiation therapy. Upon completion, the Company delivers the project to the customer and recognizes the entire revenue for it.

With the project-based operational structure mentioned, the Company has to recruit personnel in various areas such as construction, renovation, installation of various equipment and devices, and after-sales services. Additionally, the Company has to procure all the tools and equipment needed in the treatment process, along with installing the products to ensure they are fully functional.

Product Information — Overview

Introduction

Business Alignment Public Company Limited ("the Company" or "BIZ") operates the business as a distributor and installer of medical equipment for cancer treatment through radiotherapy by importing the equipment from leading manufacturers specializing in equipment and technology of cancer treatment. Maintenance services is also provided for the aforementioned medical equipment. The Company's main customers are university-affiliated hospitals, cancer hospitals under the Department of Medical Services, Ministry of Public Health, other government hospitals, healthcare agencies, and private hospitals.

The Company is the treatment delivery exclusive distributor of Thailand for Varian, A Siemens Healthnieers Company which is a globally recognized and trusted manufacturer of medical equipment and software systems for cancer treatment. The Company has been entrusted as the exclusive distributor for over 25 years, providing treatment delivery, treatment planning system, oncology information system, quality assurance software for treatment plans. In addition, the Company has other international suppliers such as A Siemens Healthnieers in Germany, IBA Dosimetry GmbH in Germany, IBA Proton Therapy in Belgium, Thermo Fisher Scientific Inc. in USA, Xstrahl Limited in UK, Deltabit Oy in Finland, Vision RT Ltd. in UK, Computerized Imaging Reference Systems, Inc. (CIRS) in USA, Radiation Product Design, Inc. in USA, and Ashland Inc. in USA. These suppliers provide high-quality and widely accepted equipment by medical professions both domestically and internationally.

Projects Under Construction

Has Projects Under Construction (Y/N)

Yes

Description

The Company has eight undelivered projects according to the consolidated financial statements for the fiscal year 2025. Referring to the accounting standards, the Company's revenue recognition occurs when the project is delivered. Therefore, any delays in project handovers, often due to the unpreparedness of clients in providing the designated space, would consequently impact the delivery date and shift the revenue recognition to subsequent accounting periods.

More Detail

มีกำหนดระยะเวลาส่งมอบภายในปี 2569 และ 2570

Total Projects

8

Total Project Value

1582.36

Recognized Value

0.0

Remaining / Unrecognized Value

1582.36

Projects

Project NameValueIncome %Est. YearsEst. Months
Distribution and Installation of Radiation Therapy Machine (1)250010
Distribution and Installation of Radiation Therapy Machine (2)117010
Distribution and Installation of Radiation Therapy Machine (3)200010
Distribution and Installation of Radiation Therapy Machine (4)421020
Distribution and Installation of Radiation Therapy Machine (5)155010
Distribution and Installation of Radiation Therapy Machine (6)180010
Distribution and Installation of Radiation Therapy Machine (7)209010
Distribution and Installation of Radiation Therapy Machine (8)49010

Debentures & Bills of Exchange

Has Debentures (Y/N)

No

Convertible Securities

Has Convertible Securities (Y/N)

No

Contents